Current and Future Clinical Applications of ctDNA in Immuno-Oncology
Testing peripheral blood for circulating tumor DNA (ctDNA) offers a minimally invasive opportunity to diagnose, characterize, and monitor the disease in individual cancer patients. ctDNA can reflect the actual tumor burden and specific genomic state of disease and thus might serve as a prognostic an...
Saved in:
Published in | Cancer research (Chicago, Ill.) Vol. 82; no. 3; pp. 349 - 358 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Association for Cancer Research
01.02.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!